Miracle-dz/UniFAR-FTUs huggingface dataset:
From Parasitism to Mutualism: Unexpected Interactions Between a Cuckoo and Its Host

Predation Favors Parasitism Parasitism in birds often results in ejection or starvation of the host's nestlings. Consequently, many host bird species have evolved protective behavior such as mobbing and parasite egg rejection. Curiously, some host species show no parasite avoidance behaviors; for example, the crow Corvus corone corone tolerates cuckoo chicks among its own brood. In a long-term study, Canestrari et al. (p. 1350) found that crow nests containing a cuckoo chick had lower rates of predation because the parasite's chicks secrete a noxious repellent substance. Overall, in years of high predation pressure, the presence of cuckoos improves the crow's breeding success, but when there are fewer predators around, parasitism reduces crow fitness. The carrion crow Corvus corone corone can benefit from parasitism by the great spotted cuckoo Clamator glandarius. Avian brood parasites lay eggs in the nests of other birds, which raise the unrelated chicks and typically suffer partial or complete loss of their own brood. However, carrion crows Corvus corone corone can benefit from parasitism by the great spotted cuckoo Clamator glandarius. Parasitized nests have lower rates of predation-induced failure due to production of a repellent secretion by cuckoo chicks, but among nests that are successful, those with cuckoo chicks fledge fewer crows. The outcome of these counterbalancing effects fluctuates between parasitism and mutualism each season, depending on the intensity of predation pressure.
Availability, indications, and technical performance of computed tomographic colonography: a national survey

Purpose: To determine the availability, indications, and technique of computed tomographic colonography (CTC) in Sweden and to investigate opinions on its future role in colon imaging. Material and Methods: In May 2004, a questionnaire on CTC was mailed to all Departments of Radiology in Sweden, and one year later a telephone interview was conducted with the departments that intended to start a CTC service. Results: Ninety-nine departments (83%) answered the questionnaire, indicating that 23/99 (23.2%) offered a CTC service. Reasons for non-implementation of CTC were lack of CTC training in 34/73 (46.6%) and non-availability of multi-detector row CT scanners in 33/73 (45.2%), while 26% were awaiting further scientific documentation on CTC. Incomplete colonoscopy was the main indication for CTC in 21/23 (91.3%) departments performing CTC. Dual positioning, room air insufflation, and thin-slice collimation were used in all the responding departments. The number of CTC studies performed varied from 1–5 (26.1%) to more than 200 (17.4%). Intravenous contrast material was routinely administered by 9/23 (39.1%) departments. Out of 30 (39.5%) departments that in 2004 intended to start CTC, 9 (30%) had done so by June 2005. A total of 32/99 (32.3%) departments had therefore started CTC by June 2005. Half of the departments that replied believed that CTC would absolutely or probably replace barium enema in the future. Conclusion: The survey shows relatively limited diffusion of CTC practice in Sweden, with approximately one-third of radiology departments offering a CTC service, mostly on a small scale. A wider dissemination of CTC requires further scientific documentation of its capability, intensified educational efforts, and additional funding.
A Proposed Trial of Dialectical Behavior Therapy and Trauma Model Therapy

Dissociative identity disorder and borderline personality disorder resemble each other in trauma histories and comorbidity. Each disorder is frequently comorbid with the other. Treatment outcome data for Dialectical Behavior Therapy of borderline personality disorder and Trauma Model Therapy of dissociative identity disorder are reviewed. The author proposes a psychotherapy treatment study in which there are three subject groups and two treatment conditions. The subject groups are borderline personality disorder without dissociative identity disorder; dissociative identity disorder without borderline personality disorder; and both conditions present concurrently. Subjects would be randomized to receive Dialectical Behavior Therapy or Trauma Model Therapy. Such a study could provide answers to controversies in the field about a better treatment approach for dissociative identity disorder and potentially could broaden and strengthen the indications for Dialectical Behavior Therapy.
Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell line.

We found that the human colon cancer cell line SW480 consists of two distinct subpopulations which we have designated E-type (epithelial) and R-type (round). Pure cultures of each type were obtained by subcloning, and both have maintained their characteristic phenotypes for at least 1 year (40 passages). E-type cells are the major (> 98%) type in the parental SW480 cell line. They form flat epithelial-like colonies. In contrast, R-type cells, which constitute a minor fraction (< 2%) of the parental cell line, have a rounded shape and grow in clusters of piled-up cells. Compared to E-type cells or the parental SW480 cells, isolated R-type cells display decreased doubling time, loss of contact inhibition, less adhesiveness to culture plates, higher anchorage-independent growth in soft agar, and a much more aneuploid karyotype. When injected s.c. into nude mice, R-type cells produce much larger tumors within the same period of time than E-type cells, and the tumors are less differentiated than those produced by the E-type cells. Cell fusion experiments between R-type and E-type cells revealed that the R-type phenotype is dominant, and the results suggest that this is due to one or a few genetic changes. Taken together, these findings suggest that the R-type cells represent a more malignant variant of the E-type cells. They may be useful, therefore, for studying mechanisms involved in tumor progression.
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity.

In a previous study, potent tumor cytolysis mediated by human neutrophil peptide defensins occurred slowly over 3 to 15 h. Because these kinetics suggested a requirement for target cell metabolic processes before tumor killing could be realized, the mechanism of lysis by these purified peptides was further investigated. 125I-labeled defensin bound extensively to peptide-sensitive K562 targets with biphasic kinetics. Binding was inhibited in parallel with cytotoxicity when both assays were performed at low temperature or in the presence of FCS. The albumin content of serum could account for the inhibitory effects of FCS. Cytotoxicity was also antagonized by agents that interfered with target cell energy metabolism (azide and 2-deoxyglucose), the cytoskeletal apparatus (cytochalasin B and dihydrocytochalasin B), lysosomal function (NH4Cl and chloraquin), or calmodulin-mediated activities (trifluoperazine). FCS also completely removed membrane-bound defensin when it was added after 5 min of binding at 37 degrees C. However, significantly less defensin was removed when FCS was added at later time points after binding was initiated. Cytochalasin B and azide/2-deoxyglucose did not prevent binding of defensin to targets but it significantly inhibited the development of FCS resistance in membrane-bound peptide. However, these two classes of inhibitors acted during distinct time windows: cytochalasin-sensitive events were complete by 1 h, whereas azide/2-deoxyglucose continued to be inhibitory when added as late as 2 h after defensins. These latter data indicated that critical energy-dependent events continue after the cytochalasin-sensitive phase has been completed. The results suggest that defensin-mediated cytotoxicity requires initial binding of defensin molecules to targets and subsequent cytoskeletal- and energy-dependent translocation or internalization. Although the defensins are low m.w. peptides, the initial processes required for their cytotoxic activity resemble those of more complex bacterial, plant and mammalian cytotoxins.
Risk factors, diet and carotid atheromatosis in TIAs and minor ischemic strokes (MISs) in a Mediterranean country

Eighty‐two patients with transient ischemic attacks (TIAs) or minor ischemic strokes (MISs) were prospectively recruited from the emergency room of a general hospital within 1 month of the event with the aim of providing a group for comparison — regarding the pathogenetic profile — with similar series from Northern Europe and USA. Patients were asked a diet questionnaire, and serum lipid analysis, CT scan and carotid duplex were performed in each case. Relevant features were antecedents of hypertension in 61%, current smoking in 23.2% and ischemic heart disease in 13.5%; mean serum levels of cholesterol 6.2 mmol/l, LDL‐ C, 4.27, HDL‐C, 1.24, triglycerides 1.45; and duplex evidence of severe extracranial carotid atheromatosis (hemodinamically significant stenosis or occlusion) in 14.4%. Relevant diet data were daily intake of energy, 7.2 MJ, fat 34% of energy and saturated fat 12.6%. Cases with severe carotid atheromatosis had significantly lower levels of HDL‐C, higher levels of triglycerides and lower per cent of energy from monounsaturated fat (p < 0.05 Mann–Whitney test). When compared with series from Northern Europe and USA ours showed lower incidence of severe carotid atheromatosis and ischemic heart disease, lower levels of triglycerides and higher HDL‐C, and lower mean diet energy and proportion of unsaturated fat We suggest that higher HDL‐C and lower triglyceride serum levels could be protective against severe extracranial carotid atheromatosis and that a Mediterranean diet, with less saturated fat and more monounsaturated fat could account in part for this low incidence of severe carotid disease in our TIAs and MISs patients.
Asymptotic Error Rate Analysis of Selection Combining on Generalized Correlated Nakagami-m Channels

From the canonical representation of the Marcum Q-function, a simple and highly accurate small argument approximation for the Marcum Q-function is first obtained. Utilizing this approximation, we derive the asymptotic error rate and outage probability expressions for multi-branch selection combining over generalized correlated Nakagami-m fading channels. These closed-form solutions can be used to provide rapid and accurate estimation of the error rates and outage probabilities in large signal-to-noise ratio regimes. It is shown that asymptotic error rates and outage probability over correlated Nakagami-m branches can be obtained by scaling the asymptotic error rates and outage probability over independent branches with a factor detm(M), where det(M) is the determinant of matrix M whose elements are the square root of the corresponding elements in the branch power covariance coefficient matrix.
First magnetomyographic recordings of uterine activity with spatial-temporal information with a 151-channel sensor array.

OBJECTIVE The purpose of this study was to examine the feasibility of recording the spatial-temporal magnetomyographic activity from the pregnant uterus with the use of the newly developed 151-channel noninvasive device, known as the superconducting quantum interference device array for reproductive assessment. STUDY DESIGN Uterine magnetomyographic signals were recorded from 10 pregnant subjects with the 151-channel sensor array curved to fit the pregnant abdomen. The recording sessions were 16 minutes in length, with a sampling rate of 250 Hz. RESULTS Uterine activity bursts were successfully recorded with the superconducting quantum interference device array for reproductive assessment system. By obtaining a contour plot of the magnetic field distribution, we were able to localize the areas of activation over the uterus during a contraction. Also, it was possible to calculate the time delay in the propagation of the activity across the uterus. CONCLUSION Using superconducting quantum interference device array for reproductive assessment system, we have established the feasibility of recording uterine contractile activity with spatial-temporal resolution that is high enough to determine the regions of localized activation and propagation over the uterus.
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient

We used a GAD65‐specific human B–T cell line cognate system in vitro to investigate the modulation of GAD65 presentation by autoantibody, assessed in a proliferation assay. Generally, if the T cell determinant overlaps or resides within the antibody epitope, effects of presentation are blunted while if they are distant can lead to potent presentation. For three different autoreactive B–T cell line cognate pairs, the modulation of GAD65 presentation followed the mode of overlapping or distant epitopes with resultant potent or undetectable presentation. However, other cognate pairs elicited variability in this pattern of presentation. Notably, one B cell line, DPC, whose antibody epitope did not overlap with the T cell determinants, was consistently poor in presenting GAD65. Using the fluorescent dye Alexa Fluor 647 conjugated to GAD65 to study receptor‐mediated antigen endocytosis showed that all the antigen‐specific B cell clones were efficient in intracellular accumulation of the antigen. Additionally, multicolour immunofluorescence microscopy showed that the internalized GAD65/surface IgG complexes were rapidly targeted to a perinuclear compartment in all GAD‐specific B cell clones. This analysis also demonstrated that HLA‐DM expression was reduced strongly in DPC compared to the stimulatory B cell clones. Thus the capability of antigen‐specific B cells to capture and present antigen to human T cell lines is dependent on the spatial relationship of B and T cell epitopes as well other factors which contribute to the efficiency of presentation.
Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia

Abstract Aim: In this study, we attempted to analyze the impact of insurance based health care system and treatment compliance on the outcome of adolescent and adults with acute lymphoblastic leukemia (ALL). Materials and Methods: Patients who underwent treatment for ALL during the period 2003-2011 were enrolled into this retrospective study. Patients on supportive or palliative care only and patients with age <10 years were excluded. The hospital records and tumor registry records were studied. Patients were stratified into two groups, Group A (prior to the introduction of state health insurance [SHI], 2003-2007) and Group B (after the introduction of SHI, 2008-2011). Overall survival (OS) was calculated using Kaplan-Meier method. Results: A total of 420 patients with suspected or confirmed ALL visited our center during the study period and 179 patients (87 in Group A and 92 in Group B) were considered for inclusion. The median age in years (range) was 18 (10-57) and 18 (10-58) respectively in Groups A and B with males more than females. Median OS (95% CI) was 9 (6.7-11.2) and 12 (7.3-16.7) months in the Groups A and B respectively (P = 0.265). Poor treatment compliance in both groups was high (36% in Group A and 41% in Group B, [P = 0.107]) with lower default rates in Group B (P = 0.019). Patients with good compliance in the total study population and the individual study groups had significantly better OS. Conclusions: Insurance based health care has improved outcomes in the present study but not compliance to treatment. Significantly better OS was observed in patients with good compliance.
Trends in practice of blood glucose control in critically ill patients in the Netherlands.

BACKGROUND Publication of the Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR) trial in 2009 and several observational studies caused a change in the recommendations for blood glucose control in intensive care patients. We evaluated local trends in blood glucose control in intensive care units in the Netherlands before and after the publication of the NICE-SUGAR trial and the revised Surviving Sepsis Campaign (SSC) guidelines in 2012. METHODS Survey focusing on the timing of changes in thresholds in local guidelines for blood glucose control and interrupted time-series analysis of patients admitted to seven intensive care units in the Netherlands from September 2008 through July 2014. Statistical process control was used to visualise and analyse trends in metrics for blood glucose control in association with the moment changes became effective. RESULTS Overall, the mean blood glucose level increased and the median percentage of blood glucose levels within the normoglycaemic range and in the hypoglycaemic range decreased, while the relative proportion of hyperglycaemic measurements increased. Changes in metrics were notable after publication of the NICE-SUGAR trial and the SSC guidelines but more frequent after changes in local guidelines; some changes seemed to appear independent of changes in local guidelines. CONCLUSION Local guidelines for blood glucose practice have changed in intensive care units in the Netherlands since the publication of the NICE-SUGAR trial and the revised SSC guidelines. Trends in the metrics for blood glucose control suggest new, higher target ranges for blood glucose control.
A double‐blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia

Abstract A double‐blind multicentre study was undertaken to compare the efficacy and safety of remoxipride in a controlled release (CR) formulation given once daily with haloperidol twice daily in patients with schizophrenic illness. In total, 114 patients were included. All were diagnosed as schizophrenic or schizophreniform according to DSM‐III. Their mean daily dose of remoxipride CR during the last week of treatment was 385 mg. In the haloperidol group the corresponding dose was 17 mg per day. The intended study period was 4 weeks with at least a one‐day washout. No significant differences were found between treatments regarding efficacy variables. The median total Brief Psychiatric Rating Scale (BPRS) score was 40 in the remoxipride CR group at start of treatment and 21 at last valid rating. For the haloperidol group the corresponding figures were 40 and 22. Treatment‐emergent extrapyramidal symptoms (Simpson and Angus rating) occurred statistically significantly more frequently and were more severe during haloperidol than during remoxipride CR treatment despite a statistically significantly higher concurrent use of anticholinergic drugs in the haloperidol group.
Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus.

To determine molecular viral components which can induce innate immune responses in human peripheral blood mononuclear cells (PBMC), we investigated the anti-neoplastic agent Newcastle disease virus (NDV) and its two spike proteins hemagglutinin-neuraminidase (HN) and fusion protein (F). NDV was an excellent inducer in PBMC of IFN-alpha production and capable of inducing upregulation of plasma membrane expression of tumor necrosis factor related apoptosis inducing ligand (TRAIL). Viral replication was not required for these responses because NDV inactivated for 5 min by UV was as good as live NDV. NDV-modified and paraformaldehyde-fixed BHK cells could also trigger IFN-alpha and TRAIL induction, indicating that contacts of responder cells with NDV-modified cell surfaces are sufficient to induce these activities in PBMC. Antibodies against HN but not F were able to block these responses. Finally we could show that HN but not F induced IFN-alpha and TRAIL in PBMC. This was possible through the use of respective gene transfectants generated with the help of Semliki Forest virus (SFV) replicase-based DNA recombinant expression systems. Upon contact with BHK cells expressing HN but not F at their cell surface, human PBMC produced IFN-alpha and some cells, including monocytes and T lymphocytes, upregulated cell surface TRAIL expression.
Time-Resolved Linewidth Enhancement Factors in Quantum Dot and Higher-Dimensional Semiconductor Amplifiers Operating at 1.55 $\mu{\hbox{m}}$

We report time-resolved measurements of the linewidth enhancement factors (-factors) , and , associated with the adiabatic carrier recovery, carrier heating, and two-photon absorption dynamical processes, respectively, in semiconductor optical amplifiers (SOAs) with different degrees of dimensionality-one InAs/InGaAsP/InP quantum dot (0-D), one InAs/InAlGaAs/InP quantum dash (1-D), and a matching InGaAsP/InGaAsP/InP quantum well (2-D)-all operating near 1.55- wavelengths. We find the lowest values in the QD SOA, 2-10, compared to 8-16 in the QW, and values of and that are also lower than in the QW. In the QD SOA, the -factors exhibit little wavelength dependence over the gain bandwidth, promising for wide-bandwidth all-optical applications. We also find significant differences in the -factors of lasers with the same structure, due to the differences between gain changes that are induced optically or through the electrical bias. For the lasers we find the QW structure instead has the lower -factor, having implications for directly modulated laser applications.
Deep brain stimulation improves survival in severe Parkinson's disease

Objectives Levodopa and other dopaminergic treatments have not had the expected effect on survival in Parkinson's disease (PD). Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to improve motor function, motor fluctuations, health-related quality of life, and to reduce medication usage and drug-induced dyskinesia in patients with severe PD refractory to medical therapy. Little however, has been described on the impact of STN-DBS on the survival of these patients. We aim in this study to examine the impact of STN-DBS on the survival of patients with severe PD. Methods Patients who were eligible for STN-DBS were given the choice of undergoing surgery or continuing on medical treatment. Those who exercised patient choice and preferred to continue with medical treatment formed a control population. All eligible patients seen in a 10-year period are included in this study. Our primary outcome measure is a difference in mortality between the two groups with a secondary measure of admission rates to residential (nursing home) care. Results 106 patients underwent STN-DBS, and 41 patients exercised patient choice and declined the procedure. The two groups were matched for age, gender, ethnicity, duration of disease, rates of pre-existing depression and Levodopa equivalent doses of anti-Parkinson's medications taken. Patients undergoing STN-DBS had significantly longer survival and were significantly less likely to be admitted to a residential care home than those managed purely medically. The statistical significance of these findings persisted after adjusting for potential confounding factors (survival: p=0.002, HR 0.29 (0.13 to 0.64) (residential care home admission: OR: 0.1 (95% CI 0.0 to 0.3; p<0.001). Interpretation We show for the first time that there is a survival advantage of DBS surgery in advanced PD. The effect of potential bias factors is examined. The survival advantage may arise for several postulated reasons, ranging from improvement in axial functions, such as swallowing, to some as yet unrecognised benefit of reduction in dopaminergic medication. These findings are of great interest to both patients with PD and the health professionals considering the treatment options for patients with severe PD.